Literature DB >> 2150037

Diastolic function in left ventricular hypertrophy: clinical and experimental relationships.

B H Lorell1, C S Apstein, E O Weinberg, M J Cunningham.   

Abstract

The evaluation of patients with left ventricular hypertrophy and the clinical syndrome of congestive heart failure requires the ability to distinguish between the etiologies of abnormal systolic contractile function and abnormalities of diastolic relaxation and filling. In patients with left ventricular hypertrophy and congestive heart failure, predominant diastolic dysfunction should be suspected when elevation of left ventricular diastolic pressure is detected in the presence of normal diastolic chamber volume or dimensions and preserved systolic shortening. The mechanisms which account for diastolic dysfunction in the presence of cardiac hypertrophy are controversial and are likely to be multiple. These mechanisms may include changes in left ventricular geometry, per se, changes in the composition of the left ventricular wall (fibrosis or alteration in collagen), and dynamic factors which modulate diastolic force inactivation (loading conditions, cytosolic calcium handling, cyclic AMP availability). In addition, recent studies suggest that hypertrophied cardiac muscle may be particularly susceptible to develop diastolic dysfunction in response to the stress of hypoxia or ischaemia.

Entities:  

Mesh:

Year:  1990        PMID: 2150037     DOI: 10.1093/eurheartj/11.suppl_g.54

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  3 in total

1.  Cardiac hypertrophy: stressing out the heart.

Authors:  Jil C Tardiff
Journal:  J Clin Invest       Date:  2006-06       Impact factor: 14.808

2.  Possible beneficial effect of olmesartan medoxomil on left atrial function in patients with hypertension : noninvasive assessment by acoustic quantification.

Authors:  Hui-Ping Gong; Wei Zhang; Li Li; Hong-Wei Tan; Zhi-Yong Ma; Xue-Zhen Zhong; Zhi-Hao Wang; Tao Song; Yun Zhang; Ming Zhong
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

Review 3.  Myocardial hypertrophy and its role in heart failure with preserved ejection fraction.

Authors:  Frank R Heinzel; Felix Hohendanner; Ge Jin; Simon Sedej; Frank Edelmann
Journal:  J Appl Physiol (1985)       Date:  2015-07-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.